Literature DB >> 3722787

Morphologic features of hepatic injury in cardiac disease and shock.

J H Lefkowitch, L Mendez.   

Abstract

One-hundred-forty postmortem liver specimens from patients with cardiac disease or pre-terminal hypotensive shock were examined in order to characterize the histopathologic features of ischemic and congestive hepatic disease. The study group included patients with arteriosclerotic, valvular or hypertensive heart disease, primary pulmonary disease with cor pulmonale, myocarditis, cardiomyopathy, and shock. The hepatic lesions included centrilobular congestion alone (10%), congestion with necrosis (77%), centrilobular necrosis with inflammatory reaction (neutrophil or mononuclear cell) (27%), cardiac sclerosis (48%) and regenerative hyperplasia (23%). Cardiac sclerosis, the most common form of hepatic fibrosis seen, consisted of eccentric thickening or occlusion of the walls of central veins and perivenular scars extending into the lobular parenchyma. Regeneration of liver cells was manifested by either liver-cell plate thickening within a retained cord-like framework or by nodular masses of hepatocytes (nodular regenerative hyperplasia). Only one case of developing cirrhosis was identified in this series. The morphologic features outlined in this study should provide a useful basis for the classification of liver injury in cardiac disease and shock.

Entities:  

Mesh:

Year:  1986        PMID: 3722787     DOI: 10.1016/s0168-8278(86)80043-5

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  17 in total

Review 1.  Hepato-cardiac disorders.

Authors:  Yasser Mahrous Fouad; Reem Yehia
Journal:  World J Hepatol       Date:  2014-01-27

2.  Inhibition of leukocyte adherence by anti-CD18 monoclonal antibody attenuates reperfusion injury in the rabbit ear.

Authors:  N B Vedder; R K Winn; C L Rice; E Y Chi; K E Arfors; J M Harlan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

Review 3.  Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.

Authors:  Morten A Karsdal; Tina Manon-Jensen; Federica Genovese; Jacob H Kristensen; Mette J Nielsen; Jannie Marie B Sand; Niels-Ulrik B Hansen; Anne-Christine Bay-Jensen; Cecilie L Bager; Aleksander Krag; Andy Blanchard; Henrik Krarup; Diana J Leeming; Detlef Schuppan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-03-12       Impact factor: 4.052

4.  Development of hepatocellular carcinoma in cardiac congestive liver fibrosis: report of a case.

Authors:  Koichiro Ohashi; Yuji Iimuro; Kazuhiro Suzumura; Seikan Hai; Shogo Tanaka; Tadamichi Hirano; Hideaki Sueoka; Seiichi Hirota; Jiro Fujimoto
Journal:  Clin J Gastroenterol       Date:  2015-04-09

5.  The liver in heart failure: a biopsy and explant series of the histopathologic and laboratory findings with a particular focus on pre-cardiac transplant evaluation.

Authors:  Christine Y Louie; Michael X Pham; Tami J Daugherty; Neeraja Kambham; John P T Higgins
Journal:  Mod Pathol       Date:  2015-03-20       Impact factor: 7.842

6.  Indices of muscle and liver dysfunction after surviving hemorrhage and prolonged hypotension.

Authors:  Carmen Hinojosa-Laborde; Robert E Shade; Patrice A Frost; John W Dutton; Gary W Muniz; Ian L Hudson; Robert Carter; Kathy L Ryan
Journal:  J Trauma Acute Care Surg       Date:  2019-07       Impact factor: 3.313

7.  Bile canaliculi are defective in hepatic involvement of organ failure and recovery of liver function is due to their secondary regeneration.

Authors:  E E Douzinas; E Vamvasakis; K Rigas; M Pitaridis; C Kittas; C Roussos
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

8.  Pulmonary hypertension imitating HELLP syndrome.

Authors:  Adam Morton
Journal:  Obstet Med       Date:  2013-07-25

9.  Liver abnormalities in cardiac diseases and heart failure.

Authors:  Alicia M Alvarez; Debabrata Mukherjee
Journal:  Int J Angiol       Date:  2011-09

10.  The two congested failing giants: heart and liver.

Authors:  Piero Portincasa
Journal:  Intern Emerg Med       Date:  2019-05-11       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.